Literature DB >> 31411069

Kidney dopamine D1-like receptors and angiotensin 1-7 interaction inhibits renal Na+ transporters.

Anees A Banday1, Andrea Diaz Diaz1,2, Mustafa Lokhandwala1.   

Abstract

The role of dopamine D1-like receptors (DR) in the regulation of renal Na+ transporters, natriuresis, and blood pressure is well established. However, the involvement of the angiotensin 1-7 (ANG 1-7)-Mas receptor in the regulation of Na+ balance and blood pressure is not clear. The present study aimed to investigate the hypothesis that ANG 1-7 can regulate Na+ homeostasis by modulating the renal dopamine system. Sprague-Dawley rats were infused with saline alone (vehicle) or saline with ANG 1-7, ANG 1-7 antagonist A-779, DR agonist SKF38393, and antagonist SCH23390. Infusion of ANG 1-7 caused significant natriuresis and diuresis compared with saline alone. Both natriuresis and diuresis were blocked by A-779 and SCH23390. SKF38393 caused a significant, SCH23390-sensitive natriuresis and diuresis, and A-779 had no effect on the SKF38393 response. Concomitant infusion of ANG 1-7 and SKF38393 did not show a cumulative effect compared with either agonist alone. Treatment of renal proximal tubules with ANG 1-7 or SKF38393 caused a significant decrease in Na+-K+-ATPase and Na+/H+ exchanger isoform 3 activity. While SCH23390 blocked both ANG 1-7- and SKF38393-induced inhibition, the DR response was not sensitive to A-779. Additionally, ANG 1-7 activated PKG, enhanced tyrosine hydroxylase activity via Ser40 phosphorylation, and increased renal dopamine production. These data suggest that ANG 1-7, via PKG, enhances tyrosine hydroxylase activity, which increases renal dopamine production and activation of DR and subsequent natriuresis. This study provides evidence for a unidirectional functional interaction between two G protein-coupled receptors to regulate renal Na+ transporters and induce natriuresis.

Entities:  

Keywords:  Na+-K+-ATPase; Na+/H+ exchanger; natriuresis; renal tubules

Mesh:

Substances:

Year:  2019        PMID: 31411069      PMCID: PMC6843046          DOI: 10.1152/ajprenal.00135.2019

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  57 in total

1.  The differential effect of angiotensin II and angiotensin 1-7 on norepinephrine, epinephrine, and dopamine concentrations in rat hypothalamus: the involvement of angiotensin receptors.

Authors:  R Pawlak; D Napiorkowska-Pawlak; Y Takada; T Urano; N Nagai; H Ihara; A Takada
Journal:  Brain Res Bull       Date:  2001-04       Impact factor: 4.077

2.  Renal proximal tubule Na,K-ATPase is controlled by CREB-regulated transcriptional coactivators as well as salt-inducible kinase 1.

Authors:  Mary Taub; Sudha Garimella; Dongwook Kim; Trivikram Rajkhowa; Facundo Cutuli
Journal:  Cell Signal       Date:  2015-10-09       Impact factor: 4.315

Review 3.  The ACE2/Angiotensin-(1-7)/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1-7).

Authors:  Robson Augusto Souza Santos; Walkyria Oliveira Sampaio; Andreia C Alzamora; Daisy Motta-Santos; Natalia Alenina; Michael Bader; Maria Jose Campagnole-Santos
Journal:  Physiol Rev       Date:  2018-01-01       Impact factor: 37.312

4.  Role of Mas receptor antagonist (A779) on pressure diuresis and natriuresis and renal blood flow in the absence of angiotensin II receptors type 1 and 2 in female and male rats.

Authors:  A Mansoori; S Oryan; M Nematbakhsh
Journal:  J Physiol Pharmacol       Date:  2014-10       Impact factor: 3.011

5.  Na+-independent transporters, LAT-2 and b0,+, exchange L-DOPA with neutral and basic amino acids in two clonal renal cell lines.

Authors:  P Gomes; P Soares-da-Silva
Journal:  J Membr Biol       Date:  2002-03-15       Impact factor: 1.843

6.  Loss of NHERF-1 expression prevents dopamine-mediated Na-K-ATPase regulation in renal proximal tubule cells from rat models of hypertension: aged F344 rats and spontaneously hypertensive rats.

Authors:  Michelle T Barati; Corey J Ketchem; Michael L Merchant; Walter B Kusiak; Pedro A Jose; Edward J Weinman; Amanda J LeBlanc; Eleanor D Lederer; Syed J Khundmiri
Journal:  Am J Physiol Cell Physiol       Date:  2017-05-17       Impact factor: 4.249

7.  In vivo characterization of the angiotensin-(1-7)-induced dopamine and gamma-aminobutyric acid release in the striatum of the rat.

Authors:  Bart Stragier; Ilina Hristova; Sophie Sarre; Guy Ebinger; Yvette Michotte
Journal:  Eur J Neurosci       Date:  2005-08       Impact factor: 3.386

Review 8.  Dopamine and renal function and blood pressure regulation.

Authors:  Ines Armando; Van Anthony M Villar; Pedro A Jose
Journal:  Compr Physiol       Date:  2011-07       Impact factor: 9.090

9.  Angiotensin-(1-7) stimulates water transport in rat inner medullary collecting duct: evidence for involvement of vasopressin V2 receptors.

Authors:  Antonio J Magaldi; Katia R Cesar; Magali de Araújo; Ana C Simões e Silva; Robson A S Santos
Journal:  Pflugers Arch       Date:  2003-10-08       Impact factor: 3.657

10.  Reduced renal dopamine D1 receptor function in streptozotocin-induced diabetic rats.

Authors:  Aditi Marwaha; Anees Ahmad Banday; Mustafa F Lokhandwala
Journal:  Am J Physiol Renal Physiol       Date:  2003-11-11
View more
  4 in total

Review 1.  Sorting nexins: role in the regulation of blood pressure.

Authors:  Juan Huang; Andrew C Tiu; Pedro A Jose; Jian Yang
Journal:  FEBS J       Date:  2021-11-30       Impact factor: 5.622

Review 2.  Renal Dopamine Receptors and Oxidative Stress: Role in Hypertension.

Authors:  Jian Yang; Van Anthony M Villar; Pedro A Jose; Chunyu Zeng
Journal:  Antioxid Redox Signal       Date:  2020-05-29       Impact factor: 8.401

Review 3.  The Role of the Renal Dopaminergic System and Oxidative Stress in the Pathogenesis of Hypertension.

Authors:  Waleed N Qaddumi; Pedro A Jose
Journal:  Biomedicines       Date:  2021-02-01

4.  Renal Dopamine Oxidation and Inflammation in High Salt Fed Rats.

Authors:  Anees A Banday; Mustafa F Lokhandwala
Journal:  J Am Heart Assoc       Date:  2019-12-27       Impact factor: 5.501

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.